Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Mr. Atul DandekarChief Strategy & Business Officer | -7,50k | 119,40k | Derivative Exercise and Sale | 10,42 - 26,34 | 24,81k | - |
| 2026-05-22 | Dr. Jason V. ColomaCEO & Director | -32,56k | 847,05k | Automatic Disposition | 26,00 - 26,02 | 379,51k | -7,90% |
| 2026-05-15 | Dr. Jason V. ColomaCEO & Director | -1,94k | 50,39k | Automatic Disposition | 26,00 | 412,07k | -0,47% |
| 2026-05-14 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15,00k | 237,05k | Derivative Exercise and Sale | 10,42 - 26,22 | - | - |
| 2026-05-04 | Mr. Atul DandekarChief Strategy & Business Officer | 14,31k | 149,06k | Derivative Exercise and Retained Stock | 10,42 | 24,81k | 136,20% |
| 2026-05-04 | Dr. Charles J. HomcyDirector | -7,42k | 0,00 | Other Disposition | - | 31,11k | -19,26% |
| 2026-04-29 | Mr. Atul DandekarChief Strategy & Business Officer | -7,50k | 112,15k | Derivative Exercise and Sale | 10,42 - 25,37 | 10,50k | - |
| 2026-04-01 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15,00k | 285,60k | Derivative Exercise and Sale | 10,42 - 31,07 | 0,00 | - |
| 2026-04-01 | Ms. Amy BachrodtInsider | -2,50k | 47,56k | Derivative Exercise and Sale | 10,42 - 30,34 | 12,97k | - |
| 2026-03-30 | Mr. Atul DandekarChief Strategy & Business Officer | -7,50k | 141,87k | Derivative Exercise and Sale | 10,42 - 30,02 | 10,50k | - |
| 2026-03-20 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15,00k | 580,14k | Derivative Exercise and Sale | 10,42 - 50,02 | 0,00 | - |
| 2026-03-10 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -30,00k | 1,20M | Derivative Exercise and Sale | 10,42 - 51,02 | 0,00 | - |
| 2026-02-27 | Mr. Atul DandekarChief Strategy & Business Officer | -7,50k | 262,57k | Derivative Exercise and Sale | 10,42 - 45,72 | 10,50k | - |
| 2026-03-02 | Ms. Amy BachrodtInsider | -5,00k | 173,91k | Derivative Exercise and Sale | 10,42 - 45,47 | 12,97k | - |
| 2026-02-02 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -15,00k | 534,03k | Derivative Exercise and Sale | 10,42 - 47,23 | - | - |
| 2026-02-02 | Ms. Amy BachrodtInsider | -5,00k | 178,12k | Derivative Exercise and Sale | 10,42 - 46,63 | 12,97k | - |
| 2026-01-29 | Mr. Atul DandekarChief Strategy & Business Officer | -7,50k | 253,84k | Derivative Exercise and Sale | 10,42 - 45,01 | 10,50k | - |
| 2026-01-22 | Ms. Amy BachrodtInsider | -5,00k | 175,51k | Derivative Exercise and Sale | 10,42 - 45,52 | 12,97k | - |
| 2026-01-07 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -25,16k | 749,17k | Derivative Exercise and Sale | 10,42 - 40,20 | 0,00 | - |
| 2026-01-06 | Dr. Catherine Angell SohnIndependent Non-Employee Director | -29,41k | 842,57k | Derivative Exercise and Sale | 10,42 - 39,11 | 0,00 | - |
| 2026-01-02 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -4,84k | 145,19k | Derivative Exercise and Sale | 10,42 - 40,43 | 0,00 | - |
| 2026-01-02 | Ms. Amy BachrodtInsider | -5,00k | 143,65k | Derivative Exercise and Sale | 10,42 - 39,57 | 12,97k | - |
| 2025-12-29 | Mr. Atul DandekarChief Strategy & Business Officer | -72,50k | 2,19M | Derivative Exercise and Sale | 10,42 - 41,13 | 10,50k | - |
| 2025-12-29 | Dr. Harold S. BernsteinPresident of Research & Development and Chief Medical Officer | -45,00k | 1,36M | Derivative Exercise and Sale | 10,42 - 40,93 | - | - |
| 2025-12-29 | Ms. Amy BachrodtInsider | -15,00k | 449,87k | Derivative Exercise and Sale | 10,42 - 41,16 | 12,97k | - |
| 2025-11-04 | Third Rock Ventures, LLCUnternehmen | -1,60M | 0,00 | Other Disposition | - | 5,42M | -22,78% |
| 2025-10-23 | Dr. Charles J. HomcyDirector | -28,42k | 0,00 | Other Disposition | - | 37,05k | -43,41% |
| 2025-09-15 | Dr. Richard H. SchellerIndependent Non-Employee Director | -20,74k | 464,03k | Verkauf | 22,37 | 0,00 | -100,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
